Panugan, Felipe M.
HRN: 04-40-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2022
CEFTRIAXONE 1G (VIAL)
04/16/2022
04/23/2022
IV
2g
Q12
Bacterial Meningitis
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes